Liver Disease
Latest News
AASLD debrief: Five drugs show promise in NAFLD (and two do not)
BOSTON – Promising new data for cotadutide, licogliflozin, tropifexor, saroglitazar, and PF-05221304 highlighted in...
Conference Coverage
ED-based HCV screening found feasible, linkage low
BOSTON – Among patients with homes, linkage to care was 59%, compared with 20% for patients who were homeless.
Conference Coverage
Heavy metals linked with autoimmune liver disease
BOSTON – Exposure to heavy metals from natural and man-made sources may contribute to development of autoimmune liver disease.
Conference Coverage
Hepatitis B debrief: Key themes that emerged at AASLD
BOSTON – Hot topics included HBV natural history, novel therapies, and prevention.
Conference Coverage
HVPG predicts clinical benefit after sustained virologic response
BOSTON – This provides, for the first time, firm evidence that HVPG can be taken as a surrogate endpoint for studies...
Conference Coverage
Pediatric study characterizes recurrent PSC
BOSTON – Recurrence was significantly associated with younger median age at time of transplant and autoimmune hepatitis.
Conference Coverage
Bezafibrate beats placebo in pruritus of chronic cholestasis: The FITCH trial
BOSTON – PPAR agonist now warrants consideration as first-line treatment for “vexing” clinical issue.
Conference Coverage
Over half of NASH patients have improvement in liver fibrosis after bariatric surgery
BOSTON – Bariatric surgery brought significant weight loss and resolution of multiple metabolic comorbidities.
Conference Coverage
Cilofexor passes phase 2 for primary biliary cholangitis
BOSTON – The nonsteroidal farnesoid X receptor agonist can reduce serum levels of liver biomarkers in patients with...
Conference Coverage
Direct-acting antiviral treatment linked to lower mortality in patients with HCC history
BOSTON – Reduced mortality in HCC patients with complete response apparently driven by achievement of sustained...